FDA
-
-
-
-
-
-
-
Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier®
-
-
-
-
-
-
-
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026
-
-
-
-
-
-
-
Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial
-
-
-
-
-
-
-
Aethlon Medical (AEMD) Treats First Patient in Australian Hemopurifier Cancer Trial
-
-
-
-
-
-
-
Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia
-
-
-
-
-
-
-
Innovation Driving Cancer's Solid Tumors Market
-
-
-
-
-
-
-
The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
-
327,418 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

